SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-032913
Filing Date
2017-05-17
Accepted
2017-05-17 06:07:04
Documents
2
Period of Report
2017-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14255
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3758
  Complete submission text file 0001209191-17-032913.txt   19543
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HATTERAS VENTURE PARTNERS III, LP 280 S. MANGUM ST., SUITE 350 DURHAM NC 27701
Business Address
Thorp Clay (Reporting) CIK: 0001592380 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38096 | Film No.: 17850237